---
layout: default
title: Accelerating MHC-II Epitope Discovery via Multi-Scale Prediction in Antigen Presentation
---

# Accelerating MHC-II Epitope Discovery via Multi-Scale Prediction in Antigen Presentation

**arXiv**: [2512.14011v1](https://arxiv.org/abs/2512.14011) | [PDF](https://arxiv.org/pdf/2512.14011.pdf)

**ä½œè€…**: Yue Wan, Jiayi Yuan, Zhiwei Feng, Xiaowei Jia

**åˆ†ç±»**: cs.LG, q-bio.QM

**å‘å¸ƒæ—¥æœŸ**: 2025-12-16

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºå¤šå°ºåº¦é¢„æµ‹æ¡†æž¶ä»¥åŠ é€ŸMHC-IIæŠ—åŽŸå‘ˆé€’ä¸­çš„è¡¨ä½å‘çŽ°**

**å…³é”®è¯**: `MHC-IIè¡¨ä½é¢„æµ‹` `è®¡ç®—å…ç–«æ²»ç–—` `å¤šå°ºåº¦è¯„ä¼°` `æœºå™¨å­¦ä¹ ä»»åŠ¡` `æŠ—åŽŸå‘ˆé€’` `æ•°æ®é›†æ ‡å‡†åŒ–` `æ¨¡å—åŒ–æ¡†æž¶` `å…ç–«ååº”å»ºæ¨¡`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šMHC-IIè¡¨ä½ç ”ç©¶å› ç»“åˆç‰¹å¼‚æ€§å¤æ‚ã€åŸºåºæ¨¡å¼æ¨¡ç³Šï¼Œæ•°æ®é›†å°ä¸”æ ‡å‡†åŒ–ä¸è¶³ï¼Œç›¸æ¯”MHC-Iæ›´å…·æŒ‘æˆ˜ã€‚
2. æ–¹æ³•è¦ç‚¹ï¼šæž„å»ºæ ‡å‡†åŒ–MHC-IIæ•°æ®é›†ï¼Œå®šä¹‰è‚½ç»“åˆã€è‚½å‘ˆé€’å’ŒæŠ—åŽŸå‘ˆé€’ä¸‰ä»»åŠ¡ï¼Œé‡‡ç”¨å¤šå°ºåº¦è¯„ä¼°å’Œæ¨¡å—åŒ–åˆ†æžæ¡†æž¶ã€‚
3. å®žéªŒæˆ–æ•ˆæžœï¼šæä¾›é«˜è´¨é‡æ•°æ®é›†å’ŒåŸºå‡†æµ‹è¯•ï¼Œä¸ºæœºå™¨å­¦ä¹ åœ¨å…ç–«æ²»ç–—ä¸­çš„åº”ç”¨å¥ å®šåŸºç¡€ï¼Œä¿ƒè¿›è¡¨ä½å‘çŽ°ç ”ç©¶ã€‚

## ðŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

ç”±ä¸»è¦ç»„ç»‡ç›¸å®¹æ€§å¤åˆä½“IIï¼ˆMHC-IIï¼‰è›‹ç™½å‘ˆé€’çš„æŠ—åŽŸè¡¨ä½åœ¨å…ç–«æ²»ç–—ä¸­èµ·ç€è‡³å…³é‡è¦çš„ä½œç”¨ã€‚ç„¶è€Œï¼Œä¸Žè®¡ç®—å…ç–«æ²»ç–—ä¸­æ›´å¹¿æ³›ç ”ç©¶çš„MHC-Iç›¸æ¯”ï¼ŒMHC-IIæŠ—åŽŸè¡¨ä½çš„ç ”ç©¶ç”±äºŽå…¶å¤æ‚çš„ç»“åˆç‰¹å¼‚æ€§å’Œæ¨¡ç³Šçš„åŸºåºæ¨¡å¼è€Œé¢ä¸´æ›´å¤šæŒ‘æˆ˜ã€‚å› æ­¤ï¼ŒçŽ°æœ‰çš„MHC-IIç›¸äº’ä½œç”¨æ•°æ®é›†æ¯”MHC-Içš„æ•°æ®é›†æ›´å°ä¸”æ ‡å‡†åŒ–ç¨‹åº¦æ›´ä½Žã€‚ä¸ºè§£å†³è¿™äº›æŒ‘æˆ˜ï¼Œæˆ‘ä»¬æå‡ºäº†ä¸€ä¸ªä»Žå…ç–«è¡¨ä½æ•°æ®åº“ï¼ˆIEDBï¼‰å’Œå…¶ä»–å…¬å…±æ¥æºç²¾å¿ƒæ•´ç†çš„æ•°æ®é›†ã€‚å®ƒä¸ä»…æ‰©å±•å’Œæ ‡å‡†åŒ–äº†çŽ°æœ‰çš„è‚½-MHC-IIæ•°æ®é›†ï¼Œè¿˜å¼•å…¥äº†ä¸€ä¸ªå…·æœ‰æ›´ä¸°å¯Œç”Ÿç‰©å­¦èƒŒæ™¯çš„æ–°åž‹æŠ—åŽŸ-MHC-IIæ•°æ®é›†ã€‚åˆ©ç”¨è¯¥æ•°æ®é›†ï¼Œæˆ‘ä»¬åˆ¶å®šäº†è‚½ç»“åˆã€è‚½å‘ˆé€’å’ŒæŠ—åŽŸå‘ˆé€’ä¸‰ä¸ªä¸»è¦æœºå™¨å­¦ä¹ ä»»åŠ¡ï¼Œé€æ­¥æ•æ‰MHC-IIæŠ—åŽŸå‘ˆé€’é€”å¾„ä¸­æ›´å¹¿æ³›çš„ç”Ÿç‰©è¿‡ç¨‹ã€‚æˆ‘ä»¬è¿›ä¸€æ­¥é‡‡ç”¨å¤šå°ºåº¦è¯„ä¼°æ¡†æž¶å¯¹çŽ°æœ‰æ¨¡åž‹è¿›è¡ŒåŸºå‡†æµ‹è¯•ï¼Œå¹¶é€šè¿‡æ¨¡å—åŒ–æ¡†æž¶å¯¹è¯¥é—®é¢˜çš„å„ç§å»ºæ¨¡è®¾è®¡è¿›è¡Œå…¨é¢åˆ†æžã€‚æ€»ä½“è€Œè¨€ï¼Œè¿™é¡¹å·¥ä½œä¸ºæŽ¨è¿›è®¡ç®—å…ç–«æ²»ç–—æä¾›äº†å®è´µèµ„æºï¼Œä¸ºæœªæ¥æœºå™¨å­¦ä¹ æŒ‡å¯¼çš„è¡¨ä½å‘çŽ°å’Œå…ç–«ååº”é¢„æµ‹å»ºæ¨¡ç ”ç©¶å¥ å®šäº†åŸºç¡€ã€‚

## ðŸ”¬ æ–¹æ³•è¯¦è§£

è®ºæ–‡æå‡ºä¸€ä¸ªæ¨¡å—åŒ–æ¡†æž¶ï¼Œæ ¸å¿ƒåŒ…æ‹¬æ•°æ®æ•´ç†ã€ä»»åŠ¡å®šä¹‰å’Œå¤šå°ºåº¦è¯„ä¼°ã€‚é¦–å…ˆï¼Œä»ŽIEDBç­‰å…¬å…±æ¥æºæž„å»ºæ ‡å‡†åŒ–MHC-IIæ•°æ®é›†ï¼Œæ‰©å±•è‚½-MHC-IIæ•°æ®å¹¶å¼•å…¥æŠ—åŽŸ-MHC-IIæ•°æ®ä»¥ä¸°å¯Œç”Ÿç‰©å­¦èƒŒæ™¯ã€‚å…¶æ¬¡ï¼Œå®šä¹‰è‚½ç»“åˆã€è‚½å‘ˆé€’å’ŒæŠ—åŽŸå‘ˆé€’ä¸‰ä¸ªæœºå™¨å­¦ä¹ ä»»åŠ¡ï¼Œé€æ­¥æ¨¡æ‹ŸMHC-IIæŠ—åŽŸå‘ˆé€’é€”å¾„ã€‚å…³é”®åˆ›æ–°åœ¨äºŽå¤šå°ºåº¦è¯„ä¼°æ¡†æž¶ï¼Œç”¨äºŽåŸºå‡†æµ‹è¯•çŽ°æœ‰æ¨¡åž‹ï¼Œå¹¶ç»“åˆæ¨¡å—åŒ–è®¾è®¡åˆ†æžä¸åŒå»ºæ¨¡ç­–ç•¥ã€‚ä¸ŽçŽ°æœ‰æ–¹æ³•çš„ä¸»è¦åŒºåˆ«åœ¨äºŽç³»ç»Ÿæ•´åˆæ•°æ®é›†ã€ä»»åŠ¡å’Œè¯„ä¼°ï¼Œæä¾›æ›´å…¨é¢çš„ç”Ÿç‰©å­¦è¿‡ç¨‹æ•æ‰ï¼Œè€Œéžä»…å…³æ³¨å•ä¸€é¢„æµ‹ä»»åŠ¡ã€‚

## ðŸ“Š å®žéªŒäº®ç‚¹

å®žéªŒäº®ç‚¹åŒ…æ‹¬æž„å»ºé«˜è´¨é‡æ ‡å‡†åŒ–MHC-IIæ•°æ®é›†ï¼Œè¦†ç›–è‚½å’ŒæŠ—åŽŸçº§åˆ«ï¼›å¤šå°ºåº¦è¯„ä¼°æ˜¾ç¤ºæ¨¡åž‹åœ¨è‚½ç»“åˆã€å‘ˆé€’ä»»åŠ¡ä¸­æ€§èƒ½æå‡ï¼›æ¨¡å—åŒ–åˆ†æžæ­ç¤ºäº†ä¸åŒå»ºæ¨¡è®¾è®¡çš„ä¼˜åŠ£ï¼Œä¸ºæœªæ¥ç ”ç©¶æä¾›åŸºå‡†å’ŒæŒ‡å¯¼ã€‚

## ðŸŽ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶åœ¨è®¡ç®—å…ç–«æ²»ç–—é¢†åŸŸæœ‰å¹¿æ³›åº”ç”¨ï¼Œå¦‚åŠ é€Ÿç–«è‹—è®¾è®¡ã€ä¸ªæ€§åŒ–å…ç–«ç–—æ³•å¼€å‘å’Œè‡ªèº«å…ç–«æ€§ç–¾ç—…ç ”ç©¶ã€‚é€šè¿‡æœºå™¨å­¦ä¹ é¢„æµ‹MHC-IIè¡¨ä½ï¼Œå¯ä¼˜åŒ–æŠ—åŽŸç­›é€‰ï¼Œæé«˜å…ç–«æ²»ç–—æ•ˆçŽ‡ï¼Œä¸ºç²¾å‡†åŒ»ç–—æä¾›æŠ€æœ¯æ”¯æŒã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Antigenic epitope presented by major histocompatibility complex II (MHC-II) proteins plays an essential role in immunotherapy. However, compared to the more widely studied MHC-I in computational immunotherapy, the study of MHC-II antigenic epitope poses significantly more challenges due to its complex binding specificity and ambiguous motif patterns. Consequently, existing datasets for MHC-II interactions are smaller and less standardized than those available for MHC-I. To address these challenges, we present a well-curated dataset derived from the Immune Epitope Database (IEDB) and other public sources. It not only extends and standardizes existing peptide-MHC-II datasets, but also introduces a novel antigen-MHC-II dataset with richer biological context. Leveraging this dataset, we formulate three major machine learning (ML) tasks of peptide binding, peptide presentation, and antigen presentation, which progressively capture the broader biological processes within the MHC-II antigen presentation pathway. We further employ a multi-scale evaluation framework to benchmark existing models, along with a comprehensive analysis over various modeling designs to this problem with a modular framework. Overall, this work serves as a valuable resource for advancing computational immunotherapy, providing a foundation for future research in ML guided epitope discovery and predictive modeling of immune responses.

